Introduction {#S0001}
============

Esophageal squamous cell carcinoma (ESCC), associates with high mortality in East Asia, is one of the histological subtypes of esophageal cancer (EC).[@CIT0001] Emerging evidence revealed that early diagnosis in ESCC could elevate the survival rates of ESCC patients.[@CIT0002] Majority of ESCC patients are diagnosed too late to get resection surgical due to the lack of biomarkers for the early detection.[@CIT0003] Therefore, it is urgent to find novel therapeutic targets for early detection in ESCC.

Long non-coding RNAs (lncRNAs) are a class \>200 nucleotides (nt) and have no translation function. Previous documents revealed that lncRNAs closely associated with chromatin remodeling, transcriptional regulation, and post-transcriptional modulation and further affect cancer.[@CIT0004] Long intergenic non-coding RNA 152 (LINC00152), an 828 bp lncRNA located on human chromosome 2p11.2, was discovered in the process of demethylation during liver cancer progression.[@CIT0005] Plenty of evidence indicated that LINC00152 was an oncogene in various malignancies including ESCC.[@CIT0006] For example, a study in gastric cancer (GC) demonstrated that LINC00152 was apparently upregulated in GC tissues and cells, and LINC00152 depletion retarded cell proliferation, migration and invasion and promoted cell apoptosis.[@CIT0007] Actually, another document unraveled that LINC00152 was significantly increased in ESCC tissues and cells (EC109, EC9706, TE-1, TE-3, KYSE150, YSE450 and KYSE30), LINC00152 knockdown inhibited cell proliferation and induced apoptosis via miR-153-3p/FYN axis in ESCC.[@CIT0008] However, the full regulatory network of LINC00152 in ESCC remains to be determined.

MicroRNAs (miRNAs), a class of small RNA about 22 nt in length, have been reported to function as message RNA (mRNA) inhibitor via blocking 3ʹUTR of mRNA or degradation pathway.[@CIT0004] Aberrant expression of miR-107 was found in various cancers including ESCC. For instance, Zhan et al, manifested that miR-107 was dramatically decreased in osteoarthritis tissues and cells, and overexpression of miR-107 hampered cell apoptosis and impelled autophagy in osteoarthritis chondrocytes.[@CIT0009] Another report in ESCC revealed that miR-107 was down-regulated in ESCC cells, and its overexpressed blocked cell proliferation, migration and invasion but promoted cell apoptosis.[@CIT0010] Ras-related protein Rab-10 (Rab10), a member of the RAS oncogene family, has been documented to play a crucial role in vesicular trafficking and associated with many types of cancers.[@CIT0011] In fact, convincing evidence showed that the miR‑378a‑3p/Rab10 axis-regulated cell proliferation, invasion and migration in ESCC cells.[@CIT0012] Nevertheless, the biological mechanism of miR-107 or Rab10 was not fully reported in ESCC. In this study, we mainly aimed to explore the mechanism of LINC00152 in ESCC.

Materials And Methods {#S0002}
=====================

Patients And Tissue Specimens {#S0002-S2001}
-----------------------------

Twenty-three tumor samples and its corresponding adjacent normal tissues were collected from ESCC patients in the Third Hospital of Hebei Medical University, and then stored in −80°C refrigerator until further using. All patients or these relatives in this program were provided informed consents. The ESCC patients were divided into two groups according to the level of LINC00152:high LINC00152 group (n=14), low LINC00152 group (n=11). This study was approved by the Ethics Committee of the Third Hospital of Hebei Medical University and performed in compliance with the Declaration of Helsinki Principles, which is also in accordance with the Guidelines for Animal Welfare Standards.

Cell Culture And Transfection {#S0002-S2002}
-----------------------------

The ESCC cell lines (TE-1 and KYSE30) and the normal human esophageal mucosal epithelial cell line (Het-1A) were purchased from Cell Bank of the Chinese Academy of Science (Shanghai, China). All the cells were cultivated in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Rockville, MD, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) in a 37°C, 5% CO~2~ incubator.

Small interfering RNA (siRNA) direct targeting LINC00152 (si-LINC00152), a scramble control (si-NC), siRNA against Rab10 (si-Rab10) and its control (si-NC), miR-107 mimic (miR-107) and mock of miR-107 (miR-NC), miR-107 inhibitor (in-miR-107) and its corresponding negative control (in-miR-NC) were brought from GenePharma (Shanghai, China). Rab10 3ʹUTR or its mutant was amplified and inserted into pcDNA vector (Hanbio, Shanghai, China), namely Rab10 or pcDNA, respectively. The transient transfection was performed using Lipo-fectamine 2000 Reagent (Invitrogen, USA) referring to the manual.

RNA Isolation And Quantitative Real-Time PCR (qRT-PCR) {#S0002-S2003}
------------------------------------------------------

Total RNA in tissues and cells were extracted using miRNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. cDNA was formed using miScript RT Kit (TaKaRa, Dalian, China). The quantitative PCR was performed using SYBR Premix Ex Taq II (TaKaRa) on ABI Prism 7700 Sequence Detection System (Thermo Fisher Scientific). The relative expression levels of LINC00152, Rab10 were normalized by glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and miR-107 was normalized by small nuclear RNA U6 and calculated with the method of 2^−ΔΔCt^. The primers were synthesized in Songon (Shanghai, China) and listed as follows: LINC00152: (Forward, 5ʹ-GAAGGTGTCGGCAAGATC-3ʹ and Reverse, 5ʹ-TCGGTGTCTGTCATATTCG-3ʹ), miR-107: (Forward, 5ʹ-AGCAGCATTGTACAGGG-3ʹ and Reverse, 5ʹ-GAATACCTCGGACCCTGC-3ʹ), Rab10: (Forward, 5ʹ-CACCGGATCGGGGATTCCGGAGTGG-3ʹ and Reverse, 5ʹ-AAACCCACTCCGGAATCCCCGATCC-3ʹ), U6: (Forward, 5ʹ-GCUUCGGCAGCACAUAUACUAAAAU-3ʹ and Reverse, 5ʹ-CGCUUCACGAAUUUGCGUGUCAU-3ʹ) and GAPDH: (Forward, 5ʹ-GGAGCGAGATCCCTCCAAAAT-3ʹ and Reverse, 5ʹ-GGCTGTTGTCATACTTCTCATGG-3ʹ).

Cell Proliferation Assay {#S0002-S2004}
------------------------

Cell Counting Kit-8 (Dojindo, Kumamoto, Japan) was used to detect the cell viability of the transfected TE-1 and KYSE30 cells according to its instructions. Briefly, TE-1 and KYSE30 cells (2×10^4^ per well) were added in 96-well plate and cultivated for 24 hrs. Following transfection and 0-hr, 24-hr, 48-hr, or 72-hr incubation, CCK8 solution was injected into each well and incubated for another 3 hrs. The colorimetric analysis at 450 nm was measured using a spectrophotometer (Multiskan MK3; Thermo Fisher Scientific).

Transwell Assays {#S0002-S2005}
----------------

Transwell assay was used to detect the migration and invasion abilities in vitro. 24-well Transwell chambers (Corning, Tewksbury, MA, USA) with polycarbonate membrane were chosen in this assay. For migration, the lower chamber added with RPMI-1640 medium containing 10% FBS, and the upper chamber supplemented with transfected cells in serum-free medium. After 48-hr incubation, cells on the lower side of the membrane were ﬁxed with 4% methanol and stained with 0.1% crystal violet. The cells in 10 random selected fields were counted using a light microscope (Olympus, Japan). For invasion, the protocol was similar to migration, while the upper chamber coated with a matrigel matrix (BD Biosciences, San Jose, CA, USA).

Dual-Luciferase Reporter Assay {#S0002-S2006}
------------------------------

The interactions between miR-107 and LINC00152 or Rab10 were predicted by starBase v2.0 ([<http://starbase.sysu.edu.cn>]{.ul}) and TargetScan ([<http://www.targetscan.org>]{.ul}), respectively. The wild type and mutant sequences of LINC00152 and Rab10 3ʹ-untranslated regions (3ʹUTR) were cloned and then inserted into luciferase vector psiCHECK2 (Promega, Madison, WI, USA), named as LINC00152 WT, LINC00152 MUT, Rab10 3ʹUTR- WT or Rab10 3ʹUTR-MUT. Subsequently, the luciferase reporter and miR-107 or miR-NC were co-transfected into TE-1 and KYSE30 cells. The luciferase reporter activity was measured using dual-luciferase reporter assay kit (Promega).

RNA Immunoprecipitation (RIP) Assay {#S0002-S2007}
-----------------------------------

For RIP assay, EZ-Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA, USA) were utilized to verify the interaction between miR-107 and LINV00152 according to its instructions. In brief, the TE-1 and KYSE30 cells lysate samples were incubated with RIP buffer containing magnetic beads linked with anti-Ago2 or anti-IgG. After elution by protease K, the level of LINC00152 was measured by qRT-PCR.

Western Blot Assay {#S0002-S2008}
------------------

The protein in TE-1 and KYSE30 cells was extracted using RIPA Lysis and Extraction Buffer (Thermo Fisher Scientific) and the concentration was assessed by BCA Protein Assay Kit (Beyotime, Shanghai, China). Subsequently, the protein samples were separated by sodium dodecyl sulfonate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto polyvinylidene fluoride (PVDF) membrane (GE Healthcare, Piscataway, NJ, USA). The membrane was blocked in no-fat milk for 4 hrs and then incubated with primary antibody overnight at 4°C. The membrane was incubated with secondary antibody at 37°C for another 2 hrs. RapidStep ECL Reagent (Millipore) was used to detect the fluorescence intensity. Rab10 (1:1000, ab230261), β-actin (1:1000, ab8227) and secondary antibody (1:25,000; ab97051) antibodies were obtained from Abcam (Cambridge, MA, USA).

Mice Model Experiments {#S0002-S2009}
----------------------

The animal experiments were approved by the Animal Care Committee of the Third Hospital of Hebei Medical University in accordance with manual. Lentiviral vectors (sh-LINC00152 and sh-NC) were purchased from Genecham. Then, the TE-1 cells (4×10^6^) transfected with sh-LINC00152 or si-NC were injected into the nude mice obtained from Shanghai Laboratory Animal Company (SLAC; Shanghai, China). The tumor volume was measured every 7 days continued 28 days and calculated according to the formula:volume (mm^3^) = width^2^ × length/2. Following the tumor excision, the xenograft tumors were weighted and frozen for further study.

Statistical Analysis {#S0002-S2010}
--------------------

All data were performed using GraphPad Prism 7 (GraphPad Inc., La Jolla, CA, USA), and exhibited as mean ± standard deviation (SD) from three independent repeats. Differences in two groups were assessed by Student\'s *t*-test, while among multigroup were processed through one-way analysis of variance (ANOVA) followed by Tukey's post hoc. *P*\<0.05 was considered statistically significant.

Results {#S0003}
=======

LINC00152 Was Upregulated In ESCC Tissues And Cell Lines {#S0003-S2001}
--------------------------------------------------------

Plenty of evidence indicated that LINC00152 was an oncogene in various malignancies. To observe the role of LINC00152 in ESCC, qRT-PCR was performed to detect the level of LINC00152 in ESCC tissues. The results showed that the level of LINC00152 was evidently increased in ESCC tissues in contrast to that in adjacent normal tissues ([Figure 1A](#F0001){ref-type="fig"}). The Kaplan-Meier curves exhibited that the survival rate of ESCC patients with high level of LINC00152 was apparently lower than that in low LINC00152 group ([Figure 1B](#F0001){ref-type="fig"}). In addition, the level of LINC00152 in cell lines also presented that LINC00152 was highly expressed in ESCC cell lines (TE-1, KYSE30) compared to that in human esophageal epithelial cell lines (Het-1A) ([Figure 1C](#F0001){ref-type="fig"}). Taken together, these results revealed the level of LINC00152 was significantly elevated in ESCC.Figure 1The level of LINC00152 in ESCC tissues and cell lines. (**A** and **C**) qRT-PCR was performed to detect the level of LINC00152 in ESCC tissues and cell lines. (**B**) The interrelation between patients' survival rate (log-rank test) and the level of LINC00152 was shown. \**P*\<0.05.

The Depletion Of LINC00152 Suppressed Cell Proliferation, Migration, And Invasion In TE-1 And KYSE30 Cells {#S0003-S2002}
----------------------------------------------------------------------------------------------------------

To observe the biological functions of LINC00152 in ESCC, loss-of-function assays were conducted in TE-1 and KYSE30 cells transfected with siRNAs (si-LINC00152\#1, si-LINC00152\#2 and si-LINC00152\#3). The results displayed that LINC00152 was dramatically down-regulated in si-LINC00152-transfected TE-1 and KYSE30 cells, suggesting the high knockdown efficiency ([Figure 2A](#F0002){ref-type="fig"} and [B](#F0002){ref-type="fig"}). Subsequently, the CCK8 results indicated that the cell viability was strikingly decreased in TE-1 and KYSE30 cells transfected with si-LINC00152 related to that in si-NC or control group ([Figure 2C](#F0002){ref-type="fig"} and [D](#F0002){ref-type="fig"}). Also, the Transwell assay demonstrated that the abilities of cell migration and invasion of TE-1 and KYSE30 cells were remarkably reduced in si-LINC00152 group than that in si-NC or control group ([Figure 2E](#F0002){ref-type="fig"} and [F](#F0002){ref-type="fig"}). These data unraveled that LINC00152 knockdown blocked cell proliferation, migration and invasion in ESCC cells.Figure 2LINC00152 knockdown affected cell proliferation ability, migration ability and invasion ability in ESCC cells. (**A, B**) Three siRNAs targeting LINC00152 (si-LINC00152\#1, si-LINC00152\#2 and si-LINC00152\#3) and si-NC was transfected into TE-1 and KYSE30 cells to examine the knockdown efficiency. (**C**--**F**) The TE-1 and KYSE30 cells were transfected with control, si-NC or si-LINC00152. (**C, D**) The cell proliferation ability was measured by CCK8 assay. (**E, F**) The migration and invasion abilities were evaluated via Transwell assay. \**P*\<0.05.

LINC00152 Directly Interacted With miR-107 {#S0003-S2003}
------------------------------------------

To investigate the mechanism of LINC00152 in ESCC, starBase v2.0 online database was used to search the putative target of LINC00152. The results showed that miR-107 had complementary sequences with LINC00152 ([Figure 3A](#F0003){ref-type="fig"}). Subsequently, dual-luciferase reporter assay was performed to verify this prediction. The luciferase activity of LINC00152 WT reporter was notably decreased in TE-1 and KYSE30 cells transfected miR-107 mimic compared with that in miR-NC treatment, while the luciferase activity of LINC00152 MUT reporter had no conspicuous change in two groups ([Figure 3B](#F0003){ref-type="fig"} and [C](#F0003){ref-type="fig"}). Furthermore, the RIP assay exhibited that Ago2 antibody enriched much more LINC00152 in TE-1 and KYSE30 cells transfected miR-107 compared with that in the IgG antibody group ([Figure 3D](#F0003){ref-type="fig"}). In addition, the qRT-PCR results illustrated that miR-107 was conspicuously reduced in ESCC tissues ([Figure 3E](#F0003){ref-type="fig"}) and cells ([Figure 3F](#F0003){ref-type="fig"}). MiR-107 was distinctly elevated in TE-1 and KYSE30 cells transfected with si-LINC00152 ([Figure 3G](#F0003){ref-type="fig"}). Meanwhile, the level of miR-107 was negatively linear correlated with the level of LINC00152 ([Figure 3H](#F0003){ref-type="fig"}). To sum, miR-107 was negatively interacted with LINC00152.Figure 3miR-107 was a target of LINC00152. (**A**) The putative complementary sequences between LINC00152 and miR-107 were predicted by starBase v2.0. (**B, C**) The luciferase activity of LINC00152 WT or LINC00152 MUT reporter was detected by dual-luciferase reporter assay. (**D**) RIP assay was performed to detect the enrichment of LINC00152 by Ago2 or IgG antibody in TE-1 and KYSE30 cells transfected with miR-107 mimic or miR-NC. (**E, F**) The level of miR-107 was detected in ESCC tissues and cells using qRT-PCR. (**G**) The level of miR-107 in si-LINC00152-transfected TE-1 and KYSE30 cells was tested by qRT-PCR. (**H**) The linear correlation between the level of LINC00152 and miR-107 was shown. \**P*\<0.05.

MiR-107 Retarded Cell Proliferation, Migration And Invasion In TE-1 And KYSE30 Cells {#S0003-S2004}
------------------------------------------------------------------------------------

In order to explore the functions of miR-107 in ESCC, miR-107 mimics or in-miR-107 was transfected into TE-1 and KYSE30 cells. The transfection efficiency was confirmed, indicated by the striking enhancement of miR-107 in TE-1 and KYSE30 cells transfected with miR-107, or the apparent decrease of miR-107 in cells transfected with in-miR-107 ([Figure 4A](#F0004){ref-type="fig"} and [B](#F0004){ref-type="fig"}). The transfection of miR-107 contributed to the distinct reduction of cell viability TE-1 and KYSE30 cells related to that in miR-NC group, while the introduction of in-miR-107 showed the opposite trend ([Figure 4C](#F0004){ref-type="fig"} and [D](#F0004){ref-type="fig"}). Also, the migration and invasion abilities were showed the same trend. Briefly, the migration and invasion abilities were obviously declined in TE-1 and KYSE30 cells transfected with miR-107, while conspicuously elevated in in-miR-107-transfected TE-1 and KYSE30 cells ([Figure 4E](#F0004){ref-type="fig"} and [F](#F0004){ref-type="fig"}). These data illustrated that miR-107 retarded ESCC progression.Figure 4MiR-107 retarded cell proliferation, migration, and invasion in TE-1 and KYSE30 cells. (**A**--**F**) The TE-1 and KYSE30 cells were transfected with miR-NC, miR-107, in-miR-NC, or in-miR-107. (**A, B**) The level of miR-107 was tested by qRT-PCR. (**C, D**) The cell viability was monitored via CCK8 assay. (**E, F**) The migration and invasion were assessed by Transwell assay. \**P*\<0.05.

LINC00152 Promoted Cell Proliferation, Migration And Invasion By Targeting miR-107 {#S0003-S2005}
----------------------------------------------------------------------------------

Based on the above results, we found that miR-107 was negatively interacted with LINC00152 in ESCC cells. To further implicate the interaction between LINC00152 and miR-107, we conducted the restoration experiment. The results showed that miR-107 was elevated in TE-1 and KYSE30 cells induced by si-LINC00152, while the promoted effect was mitigated by the emergence of miR-107 inhibitor ([Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}). Similarly, the transfection of in-miR-107 receded the constraint impact on cell viability in TE-1 and KYSE30 cells caused by si-LINC00152 ([Figure 5C](#F0005){ref-type="fig"} and [D](#F0005){ref-type="fig"}). Also, the migration and invasion abilities were suppressed by the LINC00152 knockdown in TE-1 and KYSE30 cells, but the introduction of miR-107 relieved the inhibitory effect ([Figure 5E](#F0005){ref-type="fig"} and [F](#F0005){ref-type="fig"}). These data suggested that LINC00152 accelerated cell proliferation, migration and invasion by targeting miR-107.Figure 5miR-107 attenuated the inhibitory effect on cell proliferation, migration and invasion induced by LINC00152 knockdown. (**A**--**F**) The TE-1 and KYSE30 cells were transfected with si-NC, si-LINC00152, si-LINC00152 + in-miR-NC or si-LINC00152 + in-miR-107. (**A, B**) The level of miR-107 was measured by qRT-PCR. (**C, D**) The cell viability was monitored via CCK8 assay. (**E, F**) The migration and invasion were assessed by Transwell assay. \**P*\<0.05.

Rab10 Was A Target Of miR-107 {#S0003-S2006}
-----------------------------

In order to further understand the underlying biological role of miR-107 in ESCC, the putative target of miR-107 was searched by the TargetScan. The results presented that Rab10 3ʹUTR had complementary binding sites with miR-107 ([Figure 6A](#F0006){ref-type="fig"}). Following dual-luciferase reporter assay exhibited that the transfection of miR-107 mimics led to the notable downregulation of luciferase activity of Rab10 3ʹUTR-WT reporter, but had no influence on luciferase activity of Rab10 3ʹUTR-MUT reporter ([Figure 6B](#F0006){ref-type="fig"} and [C](#F0006){ref-type="fig"}).Figure 6Rab10 directly interacted with miR-107 in ESCC. (**A**) The putative binding sites between miR-107 and Rab10 3ʹUTR were shown, as well as the mutant sequences. (**B, C**) The luciferase activity of Rab10 3ʹUTR-WT or Rab10 3ʹUTR-MUT reporter was detected by dual-luciferase reporter assay. (**D**--**F**) The mRNA and protein levels of Rab10 in ESCC tissues and cells were tested by qRT-PCR and Western blot assay. (**G, H**) The protein level of Rab10 in TE-1 and KYSE30 cells transfected with miR-107 (miR-NC) or si-LINC00152 (si-NC) was assessed by Western blot assay. (**I** and **J**) The correlation among the expression of Rab10, miR-107 and LINC00152 was shown. \**P*\<0.05.

Furthermore, the mRNA and protein levels of Rab10 were distinctly elevated in ESCC tissues and cells ([Figure 6D](#F0006){ref-type="fig"}--[F](#F0006){ref-type="fig"}). The protein level of Rab10 was significantly down-regulated in TE-1 and KYSE30 cells transfected with miR-107 mimics or si-LINC00152 ([Figure 6G](#F0006){ref-type="fig"} and [H](#F0006){ref-type="fig"}). In addition, the qRT-PCR results revealed that Rab10 was negatively linear correlated with miR-107, while LINC00152 and Rab10 presented the opposite trend ([Figure 6I](#F0006){ref-type="fig"} and [J](#F0006){ref-type="fig"}). These data unraveled that Rab10 was a target of miR-107, and its level was upregulated in ESCC.

Rab10 Accelerated Cell Proliferation, Migration And Invasion In TE-1 And KYSE30 Cells {#S0003-S2007}
-------------------------------------------------------------------------------------

To explore the functions of Rab10 in ESCC, Rab10 or si-Rab10 was transfected into TE-1 and KYSE30 cells. The qRT-PCR results showed that the level of Rab10 was markedly increased in TE-1 and KYSE30 cells transfected with Rab10, or dramatically decreased in cells transfected with si-Rab10, indicating the transfection efficiency ([Figure 7A](#F0007){ref-type="fig"} and [B](#F0007){ref-type="fig"}). The transfection of si-Rab10 resulted in the significant decline of cell viability TE-1 and KYSE30 cells, while Rab10 showed the opposite trend ([Figure 7C](#F0007){ref-type="fig"} and [D](#F0007){ref-type="fig"}). Also, the migration and invasion abilities were showed the same trend with that of cell viability. Briefly, the migration and invasion abilities were evidently upregulated in TE-1 and KYSE30 cells transfected with Rab10, while strikingly reduced in si-Rab10-transfected TE-1 and KYSE30 cells ([Figure 7E](#F0007){ref-type="fig"} and [F](#F0007){ref-type="fig"}). These data illustrated that Rab10 facilitated ESCC progression.Figure 7Rab10 accelerated cell proliferation, migration, and invasion in TE-1 and KYSE30 cells. (**A**--**F**) The TE-1 and KYSE30 cells were transfected with pcDNA, Rab10, si-NC, si-Rab10. (**A, B**) The level of miR-107 was tested by qRT-PCR. (**C, D**) The cell viability was monitored via CCK8 assay. (**E, F**) The migration and invasion abilities were assessed by Transwell assay. \**P*\<0.05.

miR-107 Inhibited Cell Proliferation, Migration And Invasion In ESCC Cells By Targeting Rab10 {#S0003-S2008}
---------------------------------------------------------------------------------------------

Next, the restoration experiment was performed to illuminate the functions between miR-107 and Rab10. The transfection of miR-107 mimics resulted in the striking reduction of the protein level of Rab10 in TE-1 and KYSE30 cells, but Rab10 overexpression mitigated the inhibitory effect ([Figure 8A](#F0008){ref-type="fig"} and [B](#F0008){ref-type="fig"}). Similarly, the transfection with Rab10 regained cell viability in TE-1 and KYSE30 cells inhibited by miR-107 mimics ([Figure 8C](#F0008){ref-type="fig"} and [D](#F0008){ref-type="fig"}). The Transwell assay presented that Rab10 overexpression alleviated the suppressive effects on migration and invasion abilities in TE-1 and KYSE30 cells induced by miR-107 ([Figure 8E](#F0008){ref-type="fig"} and [F](#F0008){ref-type="fig"}). Taken together, miR-107 blocked cell proliferation, migration and invasion in ESCC cells by targeting Rab10.Figure 8Rab10 counteracted the inhibitory effect on cell proliferation, migration and invasion in ESCC induced by miR-107 mimic. (**A**--**F**) The TE-1 and KYSE30 cells were transfected with miR-NC, miR-107, miR-107 + pcDNA or miR-107 + Rab10. (**A, B**) The level of Rab10 was measured by qRT-PCR. (**C, D**) The cell viability was monitored via CCK8 assay. (**E, F**) The migration ability and invasion ability were assessed by Transwell assay. \**P*\<0.05.

LINC00152 Positively Regulated Rab10 Expression By Sponging miR-107 {#S0003-S2009}
-------------------------------------------------------------------

To further manifested the regulatory network in LINC00152, miR-107 and Rab10, the TE-1 and KYSE30 cells were co-transfected with si-LINC00152 and in-miR-107. The results showed that the mRNA and protein levels of Rab10 were markedly decreased in si-LINC00152-transfected TE-1 and KYSE30 cells, and the introduction of miR-107 mimics partly recovered the level of Rab10 ([Figure 9A](#F0009){ref-type="fig"} and [B](#F0009){ref-type="fig"}). These data implicated that LINC00152 regulated the expression of Rab10 mediated by miR-107.Figure 9The level of Rab affected by LINC00152 and miR-107. (**A, B**) The TE-1 and KYSE30 cells were transfected with si-NC, si-LINC00152, si-LINC00152 + in-miR-NC or si-LINC00152 + in-miR-107. (**A**) The mRNA level of Rab10 was tested by qRT-PCR. (**B**) The protein level of Rab10 was examined via Western blot assay. \**P*\<0.05.

LINC00152 Knockdown Impeded Xenograft Growth In Vivo {#S0003-S2010}
----------------------------------------------------

To confirm the functional effects of LINC00152 in vivo, mice model was established. TE-1 cells transfected with sh-LINC00152 or sh-NC were injected into nude mice. As shown in [Figure 10A](#F0010){ref-type="fig"} and [B](#F0010){ref-type="fig"}, the tumor volume and weight were both significantly reduced in sh-LINC00152 group related to that in sh-NC group. Furthermore, the level of LINC00152 was drastically down-regulated and miR-107 was evidently elevated in sh-LINC00152 group compared with that in sh-NC group ([Figure 10C](#F0010){ref-type="fig"} and [D](#F0010){ref-type="fig"}). Also, the protein level of Rab10 was distinctly decreased in sh-LINC00152 group ([Figure 10E](#F0010){ref-type="fig"}). These results illustrated that the depletion of LINC00152 hampered xenograft growth in vivo.Figure 10LINC00152 knockdown inhibited xenograft growth in vivo. (**A**--**E**) The nude mice were divided into sh-NC group and sh-LINC00152 group. (**A, B**) The xenograft volume and weight were exhibited. (**C, D**) The level of LINC00152 and miR-107 was detected by qRT-PCR. (**E**) The protein level of Rab10 was measured by Western blot assay. \**P*\<0.05.

Discussion {#S0004}
==========

Esophageal squamous cell carcinoma (ESCC) is a common malignant cancer in East Asia. Emerging evidence has manifested that lncRNAs played a crucial role in many types of cancers.[@CIT0013]--[@CIT0015] In this study, we aimed to find the regulatory network of LINC00152 in ESCC. Our data showed that LINC00152 regulated Rab10 to impel cell proliferation, migration and invasion in ESCC by sponging miR-107.

Recent study indicated that the dysregulation of LINC00152 was found in various malignancies. For instance, a study in oral carcinoma showed that the level of LINC00152 was distinctly upregulated in oral carcinoma tissues.[@CIT0016] Another reporter manifested that LINC00152 was remarkably elevated in ovarian cancer tissues and cell lines, and its silencing inhibited cell proliferation while induced cell apoptosis in ovarian cancer.[@CIT0017] In the present study, we verified that LINC00152 was highly expressed in ESCC tissues and cells. Furthermore, LINC00152 knockdown suppressed cell proliferation, migration and invasion in ESCC. In addition, LINC00152 blocked xenograft tumor growth in vivo. These results confirmed that LINC00152 played a vital role in ESCC.

LncRNAs have been documented to function as competing endogenous RNAs (ceRNAs) to sponge miRNAs, thus resulting in the mRNAs abnormal expression.[@CIT0018] The aberrant expression of miR-107 has been reported in various cancers including ESCC. In this study, we found that the level of miR-107 was obviously reduced in ESCC tissues and cells (TE-1 and KYSE30). LINC00152 was validated as a sponge for miR-107. The inhibitor of miR-107 promoted cell proliferation and metastasis. Moreover, miR-107 overexpression alleviated the inhibitory effects on cell proliferation, migration and invasion induced by the depletion of si-LINC00152. In agreement with our data, a study in cervical cancer that miR-107 was down-regulated and retarded cell growth mediated by lncRNA DLG1-AS1.[@CIT0019] The similar results of miR-107 were reported in pancreatic cancer.[@CIT0020] Our results of miR-107 in ESCC were consistent with previous reports.[@CIT0010],[@CIT0021] These data demonstrated that LINC00152 promoted cell proliferation, migration and invasion in ESCC by sponging miR-107.

Rab10 has been known as a member in RAB family of small GTPases, and its aberrant expression was associated with malignancy.[@CIT0011] For example, a study in osteosarcoma showed that Rab10 knockdown inhibited cell proliferation and migration.[@CIT0022] In ESCC, a report indicated that Rab10 depletion blocked cell proliferation, migration and invasion.[@CIT0012] In this study, the qRT-PCR results showed that Rab10 was notably increased in ESCC tissues and cells. Rab10 was negatively interacted with miR-107. The silencing of Rab10 impeded cell growth and metastasis of ESCC cells. Moreover, Rab10 overexpression mitigated the inhibitory effects on cell proliferation, migration and invasion induced by miR-107. Their data illustrated that miR-107 suppressed cell proliferation, migration and invasion by targeting Rab10 in ESCC.

In conclusion, all the results unraveled that LINC00152/miR-107/Rab10 regulated cell proliferation, migration and invasion in ESCC. Moreover, it has been reported that LINC00152 regulated cell proliferation, migration and apoptosis via miR-153-3p/FYN axis in ESCC.[@CIT0008] Combined with the above regulatory network, the role of LINC00152 may play crucial role in ESCC and LINC00152/miR-107/Rab10 new regulatory pathway provides new perspective into ESCC progression, thus may provide novel therapeutic target for ESCC patients.
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